Mostrando 10 resultados de: 72
Filtros aplicados
Publisher
New England Journal of Medicine(8)
Circulation(3)
Clinica e Investigacion en Arteriosclerosis(3)
Diabetes, Obesity and Metabolism(3)
International Journal of Cardiology(3)
Área temáticas
Enfermedades(60)
Farmacología y terapéutica(36)
Medicina y salud(29)
Fisiología humana(24)
Ginecología, obstetricia, pediatría, geriatría(12)
Colchicine and aspirin in community patients with COVID-19 (ACT): an open-label, factorial, randomised, controlled trial
ArticleAbstract: Background: The large number of patients worldwide infected with the SARS-CoV-2 virus has overwhelmePalabras claves:Autores:Ali Z., Anand S.S., Avezum A.J., Bangdiwala S.I., Belley-Cote E.P., Berwanger O., Bosch J.J., Choudhri S., Dans A.L., Eikelboom J.W., Farkouh M.E., Felix Camilo, Harper W.L., Hassany M., Heenan L., Jolly S.S., Kontsevaya A., Loeb M., Lopes R.D., Pais P., Palileo-Villanueva L.M., PATRICIO LOPEZ -JARAMILLO, Rangarajan S., Sharma S.K., Tarhuni W.M., Wasserman S., Whitlock R.P., Xavier D., Xu L., Yusuf S., Yusufali A.M.Fuentes:googlescopusColombian study to assess the use of noninvasive determination of endothelium-mediated vasodilatation (CANDEV). Normal values and factors associated
ArticleAbstract: The endothelium plays a critical role in vascular homeostasis. Recently, a noninvasive method has bePalabras claves:Brachial artery, Cardiovascular Risk Factors, Endothelium-mediated vasodilation, Normal valuesAutores:Accini J.L., Barrera J.G., Bautista L.E., PATRICIO LOPEZ -JARAMILLO, Sotomayor A., Trujillo F.Fuentes:googlescopusColombian study to assess the use of noninvasive determination of the endothelium-mediated vasodilation (CANDEV) II. Does location of the occlusion device affects the accuracy of the diagnosis?
ArticleAbstract: Endothelial dysfunction (ED), which is often evaluated by flow-mediated vasodilation (FMV) in the brPalabras claves:Cardiovascular Risk Factors, Endothelial function, Flow-mediated dilatation, UltrasoundAutores:Casas J.P., Luengas C., PATRICIO LOPEZ -JARAMILLO, Silva S.Y., Silva-Sieger F.A., Villa-Roel C., Villamizar C., Villamizar N.Fuentes:googlescopusAtherogenic Dyslipidemia in Latin America: Prevalence, causes and treatment: Expert's position paper made by The Latin American Academy for the Study of Lipids (ALALIP) Endorsed by the Inter-American Society of Cardiology (IASC), the South American Society of Cardiology (SSC), the Pan-American College of Endothelium (PACE), and the International Atherosclerosis Society (IAS)
ArticleAbstract: This is an executive summary made by a group of experts named Latin American Academy for the study oPalabras claves:Autores:Acevedo M., Alonso R., Arocha I., Bryce A., Carlos Ernesto Peñaherrera, Carrera C., Chirinos J.A., Cobos L., Colan J., Gómez-Alvares E., Gómez-M J.R., Isea-Perez J.E., Lanas F., Lara J., Lorenzatti A.J., Lozada A.F., Machado-H L.T., Medina J., Medina-Palomin F., Merchan-V A., Morales E., Paniagua M., PATRICIO LOPEZ -JARAMILLO, Pinto X., Piskorz D.L., Ponte-Negretti C.I., Ullauri V.E., Varleta P., Villar-M R.A., Wyss-Q F.S.Fuentes:scopusBasal insulin and cardiovascular and other outcomes in dysglycemia
ArticleAbstract: Background: The provision of sufficient basal insulin to normalize fasting plasma glucose levels mayPalabras claves:Autores:Abdallah A., Ahmad S., AHUAD GUERRERO R.A., Alebuena A., Alvarez N., Alzogaray M., Amuchastegui M., Andres M., Angos M., Avezum A.J., Baglivo H., Bahit M.C., Barbieri M., Bassi F., Bello F., Birkeland K.I., Bogaty P.M., Bono J., Bordeleau L., Bosch J.J., Budaj A.J., Bustamante Labarta M., Bustos B., Cardona E., Chacόn C., Chandra J., Chandra R., Chazova I.E., Commerford P.J., Corson M., Cukierman-Yaffee T., Dagenais G.R., Danilova L., Davies M., Díaz R., Dyal L., Fernando R., Fodor G.J., Gerstein H.C., Gilbert R., Gomis R., Halon D., Hâncu N., Hanefeld M., Harper W.L., Hildebrandt P., Johnston P., Joldersma L., Jung H., Kacerovsky-Bielesz G., Keltai M., Kim J.H., Krum H., Kultursay H., Lanas F.T., Lewis B.S., Lonn E.M., MacRae L., MacRae S., Maggioni A.P., Magloire P., Malik S., Mann J.F.E., Marin-Neto J.A., Marre M., McKelvie R., McQueen M.J., Mead A., Mendoza I., Morillo C.A., Pan C., Pasha F., PATRICIO LOPEZ -JARAMILLO, Pavlova V., Pazmino-Canizares J., Pirags V., Pogue J., Pohl K., Probstfield J.L., Profozic V., Punthakee Z., Ramachandran A., Ratner R., Richardson L., Riddle M.C., Rosenstock J., Rydén L.E., Sakalas A., Silva J., Spinas G.A., Sreenan S., Stoel I., Syvänne M., Tsang B., Tyrwhitt J., Vige R., Yakubovich N., Yale J.F., Yusuf S.Fuentes:scopusBlood-pressure and cholesterol lowering in persons without cardiovascular disease
ArticleAbstract: BACKGROUND Elevated blood pressure and elevated low-density lipoprotein (LDL) cholesterol increase tPalabras claves:Autores:Accini J.L., Avezum A.J., Bosch J.J., Chazova I.E., Dagenais G.R., Dans A.M., DIaz R., Held C., Jansky P., Jung H., Keltai K., Keltai M., Khunti K., Leiter L.A., Lewis B.S., Liu L., Lonn E.M., McKelvie R., Pais P., Parkhomenko A.N., PATRICIO LOPEZ -JARAMILLO, Peters R.J.G., Piegas L.S., Pogue J., Reid C.M., Sliwa K., Toff W.D., Varigos J.D., Xavier D., Yusoff K., Yusuf S., Zhu J.Fuentes:googlescopusBlood-pressure lowering in intermediate-risk persons without cardiovascular disease
ArticleAbstract: BACKGROUND Antihypertensive therapy reduces the risk of cardiovascular events among high-risk personPalabras claves:Autores:Avezum A.J., Bosch J.J., Chazova I.E., Dagenais G.R., Dans A.M., DIaz R., Held C., Jansky P., Jung H., Keltai K., Keltai M., Khunti K., Leiter L.A., Lewis B.S., Liu L., Lonn E.M., McKelvie R., Molina D.I., Pais P., Parkhomenko A.N., PATRICIO LOPEZ -JARAMILLO, Peters R.J.G., Piegas L.S., Pogue J., Reid C.M., Sliwa K., Toff W.D., Varigos J.D., Wilkinson J., Xavier D., Yusoff K., Yusuf S., Zhu J.Fuentes:googlescopusC-reactive protein and cardiovascular diseases in Andean population.
OtherAbstract:Palabras claves:Autores:Casas J.P., Morillo C.A., PATRICIO LOPEZ -JARAMILLOFuentes:googlescopusAntihypertensives and Statin Therapy for Primary Stroke Prevention: A Secondary Analysis of the HOPE-3 Tria
ArticleAbstract: Background and Purpose: The HOPE-3 trial (Heart Outcomes Prevention Evaluation-3) found that antihypPalabras claves:Blood pressure, candesartan, Cardiovascular disease, Lipoprotein, Primary Prevention, statinAutores:Avezum A.J., Bosch J.J., Chazova I.E., Dagenais G.R., Gao P., Hart R.G., Held C., Khunti K., Leiter L.A., Lewis B.S., Lonn E.M., Pais P., PATRICIO LOPEZ -JARAMILLO, Peters R.J.G., Reid C.M., Sliwa K., Toff W.D., Yusoff K., Yusuf S., Zhu J.Fuentes:googlescopusA controlled, randomized-blinded clinical trial to assess the efficacy of a nitric oxide releasing patch in the treatment of cutaneous leishmaniasis by Leishmania (V.) panamensis
ArticleAbstract: A topical nanofiber nitric oxide (NO) releasing patch (≈3.5 μmol NO/cm2/day for 20 days, NOP) was coPalabras claves:Autores:García C., García-Gómez R.G., Kampeerapappun P., López M., PATRICIO LOPEZ -JARAMILLO, Rincon M.Y., Silva S.Y., Smith D.J., Smith E., Vélez I.D.Fuentes:googlescopus